Valuation: BioElectronics Corporation

Market Cap 12.35M 10.57M 9.89M 9.06M 17.03M 1.18B 17.37M 117M 45.61M 592M 46.38M 45.37M 1.96B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22M 20.56M 18.85M 35.42M 2.46B 36.12M 243M 94.87M 1.23B 96.47M 94.37M 4.09B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+33.33%
Current month+33.33%
1 month+60.00%
3 months+6.95%
6 months+60.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 2019-11-14
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 2019-11-14
Chairman 85 2020-06-14
Director/Board Member - 2024-12-02
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+33.33%+100.00%-20.00% 4.94M
+2.28%+4.07%+25.94%+17.88% 227B
+2.09%+4.92%+1.75%-14.12% 149B
-5.84%-6.68%-21.85%+30.96% 141B
-5.08%-3.99%-52.41%-1.63% 75.37B
-2.65%-3.46%+13.81%+17.30% 53.19B
-0.43%+2.00%-16.51%-12.52% 51.88B
+0.57%+5.44%+30.13%+31.07% 43.89B
-2.68%-2.75%+35.93%+49.89% 40.86B
-0.75%+2.46%+0.12%+8.34% 33.7B
Average -0.64%+1.24%+11.69%+10.72% 81.49B
Weighted average by Cap. +0.25%+1.31%+2.20%+12.44%

Financials

2020 2021
Net sales 830K 710K 664K 608K 1.14M 79.39M 1.17M 7.86M 3.06M 39.76M 3.11M 3.05M 132M 1.61M 1.38M 1.29M 1.18M 2.22M 154M 2.26M 15.25M 5.94M 77.14M 6.04M 5.91M 256M
Net income -1.16M -993K -928K -851K -1.6M -111M -1.63M -10.99M -4.28M -55.58M -4.35M -4.26M -184M -290K -248K -232K -213K -400K -27.73M -407K -2.75M -1.07M -13.89M -1.09M -1.06M -46.09M
Net Debt 13.07M 11.19M 10.46M 9.58M 18.01M 1.25B 18.37M 124M 48.25M 626M 49.06M 48M 2.08B 13.34M 11.42M 10.68M 9.79M 18.39M 1.28B 18.76M 126M 49.26M 639M 50.09M 49M 2.12B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
26-08-20 US$0.000250 +25.00% 1,700,000
26-08-19 US$0.000200 -33.33% 10,833,750
26-08-18 US$0.000300 -.--% 1,755,250
26-08-17 US$0.000300 -.--% 11,130,500
26-08-14 US$0.000300 -.--% 5,949,996
  1. Stock Market
  2. Stocks
  3. BIEL Stock